137 related articles for article (PubMed ID: 6606214)
41. Factor VIII-related antigen (VIII R:AG) in haemophilic patients and in carriers.
Bowie EJ; Fass DN
Lancet; 1979 Nov; 2(8151):1049-50. PubMed ID: 91786
[TBL] [Abstract][Full Text] [Related]
42. [Adenoidectomy and tonsillectomy in children with hemophilia and von Willebrand disease].
Thach-Toan ; Gazengel C; François M; Torchet MF; Dautzenberg MD; Roulleau P
Ann Otolaryngol Chir Cervicofac; 1985; 102(6):449-56. PubMed ID: 3879138
[TBL] [Abstract][Full Text] [Related]
43. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
Weiss HJ; Sussman II; Hoyer LW
J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
[TBL] [Abstract][Full Text] [Related]
44. The spectrum of von Willebrand's disease revisited.
Bowie EJ; Fass DN; Olson JD; Owen CA
Mayo Clin Proc; 1976 Jan; 51(1):35-41. PubMed ID: 765637
[TBL] [Abstract][Full Text] [Related]
45. Haemophilia A and von Willebrand's disease in a Swedish family.
Holmberg L; Nilsson IM
Acta Paediatr Scand; 1972 Sep; 61(5):517-25. PubMed ID: 4626467
[No Abstract] [Full Text] [Related]
46. [Physiopathology and therapy of hemophilia and von Willebrand's disease].
Fukui H
Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):866-74. PubMed ID: 1919201
[No Abstract] [Full Text] [Related]
47. Measurement of antihaemophilic factor A antigen (VII:CAg) with a solid phase immunoradiometric method based on homologous non-haemophilic antibodies.
Holmberg L; Borge L; Ljung R; Nilsson IM
Scand J Haematol; 1979 Jul; 23(1):17-24. PubMed ID: 91190
[TBL] [Abstract][Full Text] [Related]
48. [Characterization of immune disorders in hemophiliac patients with the identification of inhibitor-dependence in replacement transfusion therapy].
Rudenko VP; Stasyshyn OV; Lebed' HB; Orlyk VV; Lohins'kyĭ VIe
Lik Sprava; 2001; (3):39-43. PubMed ID: 11560024
[TBL] [Abstract][Full Text] [Related]
49. Precipitating anti-VIII:C antibodies in two patients with haemophilia A.
Lavergne JM; Meyer D; Girma JP; Larrieu MJ
Br J Haematol; 1982 Jan; 50(1):135-46. PubMed ID: 6798988
[TBL] [Abstract][Full Text] [Related]
50. Immune status of HIV and HCV negative haemophiliacs treated with intermediate-purity factor VIII concentrates.
Funk M; Ebener U; Kreuz W; Ehrenforth S
Lancet; 1993 Oct; 342(8876):933-4. PubMed ID: 7692198
[No Abstract] [Full Text] [Related]
51. The defect in hemophilic and von Willebrand's disease plasmas studied by a recombination technique.
Cooper HA; Wagner RH
J Clin Invest; 1974 Nov; 54(5):1093-9. PubMed ID: 4213756
[TBL] [Abstract][Full Text] [Related]
52. Absence of hepatitis A after treatment with pasteurised factor VIII concentrates in children with haemophilia A and von Willebrand disease.
Kreuz W; Klarmann D; Auerswald G; Auberger K; Gürtler L; Rabenau H; Doerr WD
Lancet; 1993 Feb; 341(8842):446. PubMed ID: 8094219
[No Abstract] [Full Text] [Related]
53. Recent advances in haemophilia and von Willebrand's disease.
Ekert H; Firkin BG
Vox Sang; 1975; 28(6):409-21. PubMed ID: 125001
[No Abstract] [Full Text] [Related]
54. [Biological half-time of factor VIII antigen (antihemophilic globulin) in hemophilia A and in von Willebrand's disease].
Uszyński L
Acta Haematol Pol; 1974; 5(3):189-94. PubMed ID: 4546992
[No Abstract] [Full Text] [Related]
55. An in vivo study of a new factor VIII high purity preparation.
Thorell L; Blombäck M; Blombäck B
Thromb Res; 1983 Jul; 31(2):375-85. PubMed ID: 6415854
[TBL] [Abstract][Full Text] [Related]
56. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
Gralnick HR; Coller BS; Sultan Y
J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
[TBL] [Abstract][Full Text] [Related]
57. Severe factor VIII and factor IX deficiency in females.
Lusher JM; McMillan CW
Am J Med; 1978 Oct; 65(4):637-48. PubMed ID: 309282
[TBL] [Abstract][Full Text] [Related]
58. Treatment of von Willebrand's disease.
Mannucci PM
J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
[TBL] [Abstract][Full Text] [Related]
59. Immunoglobulin levels in haemophiliacs at HIV seroconversion and during follow up.
Blombäck M; Kjellman H; Schulman S; Egberg N; Böttiger B; Wiechel B
Infection; 1987; 15(4):248-52. PubMed ID: 3499399
[TBL] [Abstract][Full Text] [Related]
60. Congenital bleeding disorders: hemophilia and von Willebrand's disease.
Gill FM
Med Clin North Am; 1984 May; 68(3):601-15. PubMed ID: 6431208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
